Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19862648 | 0.95 | PTPN1 (0.38) | PTPN1ABCB1MEN1KMT2AFFAR4 | |
| SCHEMBL17358262 | 0.92 | PTPN1 (0.47) | PTPN1ABCB1MEN1KMT2AFFAR1 | |
| SCHEMBL11050221 | 0.89 | FFAR4 (0.53) | PTPN1MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL11052302 | 0.89 | FFAR4 (0.53) | PTPN1MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL11967205 | 0.87 | LMNA (0.43) | PTPN1ABCB1MEN1KMT2ATSHR | |
| SCHEMBL20465964 | 0.87 | LMNA (0.43) | PTPN1ABCB1MEN1KMT2ATSHR | |
| SCHEMBL12168157 | 0.87 | LMNA (0.43) | PTPN1ABCB1MEN1KMT2ATSHR | |
| SCHEMBL17358260 | 0.86 | PTPN1 (0.43) | PTPN1ABCB1MEN1KMT2AFFAR1 | |
| SCHEMBL14256441 | 0.85 | FFAR4 (0.48) | PTPN1MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL17358270 | 0.85 | FFAR4 (0.48) | PTPN1MEN1KMT2AFFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9969703-B2 | Triazine-containing photocurable resin and preparation method thereof | JIANGNAN UNIVERSITY (CN) | 2018-05-15 | — | — | US | disclosed |
| US-20180044301-A1 | TRIAZINE-CONTAINING PHOTOCURABLE RESIN AND PREPARATION METHOD THEREOF | JIANGNAN UNIVERSITY (CN) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044301-A1 | TRIAZINE-CONTAINING PHOTOCURABLE RESIN AND PREPARATION METHOD THEREOF | ALOX5, ALKBH5, ALOX15 | PTPN1 4278/4885ABCB1 3628/4885MEN1 4633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.